Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Ocular Therapeutix, Inc. | OCUL | 19.69M | $193.32M |
Altimmune, Inc. | ALT | 19.25M | $58.52M |
Atai Beckley Inc. | ATAI | 14.42M | $75.98M |
COMPASS Pathways plc | CMPS | 12.16M | $172.09M |
Aclaris Therapeutics, Inc. | ACRS | 9.35M | $49.44M |
Immunovant, Inc. | IMVT | 9.34M | $359.91M |
Nurix Therapeutics, Inc. | NRIX | 7.74M | $187.69M |
MoonLake Immunotherapeutics | MLTX | 7M | $136.27M |
Alumis Inc. | ALMS | 6.35M | $178.65M |
CorMedix Inc. | CRMD | 6.27M | $49.25M |
MannKind Corporation | MNKD | 6M | $25.56M |
Verastem, Inc. | VSTM | 5.74M | $21.93M |
Genmab A/S | GMAB | 5.65M | $155.21M |
Vaxcyte, Inc. | PCVX | 4.3M | $249.96M |
Tango Therapeutics, Inc. | TNGX | 4.2M | $131.29M |
Bicara Therapeutics Inc. Common Stock | BCAX | 4.1M | $121.73M |
Vera Therapeutics, Inc. | VERA | 4M | $171.64M |
Alkermes plc | ALKS | 4M | $209.58M |
Tarsus Pharmaceuticals, Inc. | TARS | 3.67M | $230.79M |
Hemab Therapeutics Holdings, Inc. Common Stock | COAG | 3.6M | $132.3M |